Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares RepurchasedShort-Term Debt repayments
Ratios

Pediatrix Medical (MD) EBIAT (2016 - 2025)

Pediatrix Medical (MD) has disclosed EBIAT for 17 consecutive years, with $45.6 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIAT rose 49.59% to $45.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $177.3 million, a 278.97% increase, with the full-year FY2025 number at $216.4 million, up 318.47% from a year prior.
  • EBIAT was $45.6 million for Q4 2025 at Pediatrix Medical, down from $71.7 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $71.7 million in Q3 2025 to a low of -$153.0 million in Q2 2024.
  • A 5-year average of $9.6 million and a median of $25.8 million in 2021 define the central range for EBIAT.
  • Peak YoY movement for EBIAT: surged 1261.2% in 2021, then crashed 641.07% in 2024.
  • Pediatrix Medical's EBIAT stood at $24.5 million in 2021, then increased by 13.17% to $27.8 million in 2022, then crashed by 547.54% to -$124.3 million in 2023, then soared by 124.52% to $30.5 million in 2024, then surged by 49.59% to $45.6 million in 2025.
  • Per Business Quant, the three most recent readings for MD's EBIAT are $45.6 million (Q4 2025), $71.7 million (Q3 2025), and $39.3 million (Q2 2025).